WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H592544
CAS#: 56693-13-1
Description: Mociprazine is a biochemical.
Hodoodo Cat#: H592544
Name: Mociprazine
CAS#: 56693-13-1
Chemical Formula: C22H32N2O3
Exact Mass: 372.24
Molecular Weight: 372.509
Elemental Analysis: C, 70.94; H, 8.66; N, 7.52; O, 12.88
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Mociprazine
IUPAC/Chemical Name: alpha-(((1-Ethynylcyclohexyl)oxy)methyl)-4-(o-methoxyphenyl)-1-piperazineethanol
InChi Key: UWDDRCRFIZGSCD-UHFFFAOYSA-N
InChi Code: InChI=1S/C22H32N2O3/c1-3-22(11-7-4-8-12-22)27-18-19(25)17-23-13-15-24(16-14-23)20-9-5-6-10-21(20)26-2/h1,5-6,9-10,19,25H,4,7-8,11-18H2,2H3
SMILES Code: OC(COC1(C#C)CCCCC1)CN2CCN(C3=CC=CC=C3OC)CC2
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 372.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Enreille A, Pognat JF, Galmier MJ, Lartigue-Mattei C, Chabard JL, Busch N, Berger JA. N-dephenylated and N-phenyl urinary metabolites of mociprazine (CERM 3517) in beagle dogs after oral administration. A mass spectrometric determination. Eur J Drug Metab Pharmacokinet. 1991 Apr-Jun;16(2):161-72. PubMed PMID: 1936075.
2: Pognat JF, Enreille A, Chabard JL, Busch N, Berger JA. N-dephenylation of CERM 3517 (mociprazine) in beagle dogs. A mass spectrometric determination. Drug Metab Dispos. 1986 Mar-Apr;14(2):147-54. PubMed PMID: 2870887.